PH12022550474A1 - Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone - Google Patents
Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidoneInfo
- Publication number
- PH12022550474A1 PH12022550474A1 PH1/2022/550474A PH12022550474A PH12022550474A1 PH 12022550474 A1 PH12022550474 A1 PH 12022550474A1 PH 12022550474 A PH12022550474 A PH 12022550474A PH 12022550474 A1 PH12022550474 A1 PH 12022550474A1
- Authority
- PH
- Philippines
- Prior art keywords
- polyvinylpyrrolidone
- diquafosol
- aqueous ophthalmic
- ophthalmic composition
- salt
- Prior art date
Links
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 title abstract 4
- 229950003529 diquafosol Drugs 0.000 title abstract 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title abstract 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title abstract 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 title abstract 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 abstract 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 2
- 206010013774 Dry eye Diseases 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- 229910001961 silver nitrate Inorganic materials 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019154525 | 2019-08-27 | ||
| PCT/JP2020/031917 WO2021039748A1 (ja) | 2019-08-27 | 2020-08-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12022550474A1 true PH12022550474A1 (en) | 2023-03-06 |
Family
ID=74685901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2022/550474A PH12022550474A1 (en) | 2019-08-27 | 2020-08-25 | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone |
Country Status (7)
| Country | Link |
|---|---|
| JP (3) | JP6966667B2 (enExample) |
| KR (2) | KR102656181B1 (enExample) |
| CN (2) | CN114286670B (enExample) |
| MY (1) | MY209059A (enExample) |
| PH (1) | PH12022550474A1 (enExample) |
| TW (1) | TWI848171B (enExample) |
| WO (1) | WO2021039748A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202007977RA (en) * | 2018-02-28 | 2020-09-29 | Santen Pharmaceutical Co Ltd | Ophthalmic composition comprising diquafosol and cationic polymer |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP7175431B1 (ja) | 2021-03-30 | 2022-11-18 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| CN114646705A (zh) * | 2022-03-22 | 2022-06-21 | 武汉绿合医药科技有限公司 | 一种地夸磷索钠滴眼液有关物质含量检测方法 |
| JP2024043685A (ja) * | 2022-09-20 | 2024-04-02 | 参天製薬株式会社 | ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法 |
| JP7245383B1 (ja) | 2022-09-20 | 2023-03-23 | 参天製薬株式会社 | ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法 |
| KR20250160050A (ko) | 2024-05-03 | 2025-11-11 | 삼천당제약주식회사 | 물리화학적 특성이 개선된 안구건조증 예방 또는 치료용 약학 조성물 |
| CN119970633A (zh) * | 2025-03-26 | 2025-05-13 | 苏州乐珠制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0365270A (ja) | 1989-07-31 | 1991-03-20 | Kanzaki Paper Mfg Co Ltd | 塗布シートの製造方法 |
| JPH0365270U (enExample) | 1989-10-31 | 1991-06-25 | ||
| US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| CA2125060C (en) * | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| KR100549904B1 (ko) * | 1996-03-27 | 2006-05-16 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 우리딘트리포스페이트및관련화합물을함유하는섬모운동장해치료용약학조성물 |
| US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| US6274626B1 (en) * | 1998-12-22 | 2001-08-14 | Bausch & Lomb Incorporated | Pheniramine-containing compositions and method for treating allergic responses |
| WO2001047532A1 (en) * | 1999-12-27 | 2001-07-05 | Santen Pharmaceutical Co., Ltd. | System for stabilizing lacrimal fluid layer |
| AU2001260643B9 (en) * | 2000-05-30 | 2006-10-19 | Merck Sharp & Dohme Corp. | Ectocornea extension promoters |
| KR101389300B1 (ko) * | 2005-02-14 | 2014-04-25 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 안과용 렌즈의 제조방법, 안과용 장치 및 콘택트 렌즈 |
| CA2810481C (en) * | 2010-09-10 | 2018-06-19 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| AU2011350762B2 (en) * | 2010-12-28 | 2017-04-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| KR20120077080A (ko) | 2010-12-30 | 2012-07-10 | 동우 화인켐 주식회사 | 광학필름 및 이를 이용한 백라이트 유닛 |
| US20160213708A1 (en) * | 2012-01-08 | 2016-07-28 | Medicure Technologies Ltd. | Ophthalmic composition |
| MY169816A (en) * | 2012-03-26 | 2019-05-16 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol |
| JP2015032653A (ja) | 2013-08-01 | 2015-02-16 | 株式会社東芝 | 固体撮像装置 |
| JP6267003B2 (ja) | 2014-02-27 | 2018-01-24 | 参天製薬株式会社 | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 |
| EP3139903B1 (en) * | 2014-05-07 | 2019-07-03 | Croma-Pharma Gesellschaft m.b.H. | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| EA034517B1 (ru) * | 2014-12-25 | 2020-02-17 | Сантен Фармасьютикал Ко., Лтд. | Водный офтальмологический раствор |
| WO2016195072A1 (ja) * | 2015-06-05 | 2016-12-08 | 参天製薬株式会社 | ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤 |
| CN107837276A (zh) * | 2016-09-19 | 2018-03-27 | 刘力 | 局部给药的药物组合物 |
| SG11202007977RA (en) * | 2018-02-28 | 2020-09-29 | Santen Pharmaceutical Co Ltd | Ophthalmic composition comprising diquafosol and cationic polymer |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
-
2020
- 2020-08-25 JP JP2021521065A patent/JP6966667B2/ja active Active
- 2020-08-25 KR KR1020227009546A patent/KR102656181B1/ko active Active
- 2020-08-25 WO PCT/JP2020/031917 patent/WO2021039748A1/ja not_active Ceased
- 2020-08-25 TW TW109128895A patent/TWI848171B/zh active
- 2020-08-25 CN CN202080059970.2A patent/CN114286670B/zh active Active
- 2020-08-25 PH PH1/2022/550474A patent/PH12022550474A1/en unknown
- 2020-08-25 MY MYPI2022001012A patent/MY209059A/en unknown
- 2020-08-25 KR KR1020247011257A patent/KR20240049646A/ko active Pending
- 2020-08-25 CN CN202311818685.6A patent/CN117771172A/zh active Pending
-
2021
- 2021-10-20 JP JP2021171358A patent/JP7614069B2/ja active Active
-
2024
- 2024-12-25 JP JP2024228577A patent/JP7902251B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021039748A1 (ja) | 2021-03-04 |
| KR20220052971A (ko) | 2022-04-28 |
| MY209059A (en) | 2025-06-18 |
| JP2025031918A (ja) | 2025-03-07 |
| JPWO2021039748A1 (ja) | 2021-09-30 |
| JP2022003099A (ja) | 2022-01-11 |
| CN117771172A (zh) | 2024-03-29 |
| KR102656181B1 (ko) | 2024-04-08 |
| TWI848171B (zh) | 2024-07-11 |
| JP7902251B2 (ja) | 2026-08-07 |
| JP6966667B2 (ja) | 2021-11-17 |
| TW202122094A (zh) | 2021-06-16 |
| CN114286670A (zh) | 2022-04-05 |
| JP7614069B2 (ja) | 2025-01-15 |
| KR20240049646A (ko) | 2024-04-16 |
| CN114286670B (zh) | 2024-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY209059A (en) | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone | |
| ZA202100208B (en) | Heterocyclic and heteroaryl compounds for treating huntington's disease | |
| PH12019501902A1 (en) | Ocular formulations for drug-delivery to the posterior segment of the eye | |
| EA201991299A1 (ru) | Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов | |
| EA201200490A1 (ru) | Стабильный совместный состав, содержащий хиалуронидазу и иммуноглобулин, и способы его применения | |
| GR3005586T3 (enExample) | ||
| EA201890196A1 (ru) | Композиция для устранения заложенности носа, обладающая противовирусным действием | |
| EA201792559A1 (ru) | Фармацевтические композиции для местного применения | |
| WO2018089328A8 (en) | TREATMENT OF CNS DISEASES USING GCS STIMULATORS | |
| AU2020231934A8 (en) | Compounds useful in HIV therapy | |
| PH12017501222B1 (en) | Glucagon derivatives with improved stability | |
| MY206814A (en) | Antiviral immunotropic agent for the treatment of acute respiratory viral infections | |
| SI3055325T1 (en) | NEW DERIVATIVE ANALOGUE INSULINE | |
| HRP20250792T1 (hr) | Formulacije anhidriranog natrij tiosulfata | |
| JP2022003099A5 (enExample) | ||
| JP2014237607A (ja) | ペメトレキセドを含む注射用組成物 | |
| SG11201901617PA (en) | Azole compound ophthalmic preparation | |
| MX2025007278A (es) | Soluciones novedosas | |
| CR20230532A (es) | ESTIMULADORES DE GUANILIL CICLASA SOLUBLE (sGC) | |
| WO2019083286A3 (ko) | 아이론을 유효성분으로 포함 하는 탈모 방지 또는 발모 촉진용 조성물 | |
| NZ773672A (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | |
| NO940064L (no) | Öyepreparat på polyakrylsyrebasis | |
| BR112022009153A2 (pt) | Compostos inibidores de óxido de nitrogênio pde-5 e/ou pde-6 | |
| WO2019083287A3 (ko) | 펠란드렌을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
| WO2020047360A8 (en) | Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease |